Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
November 2, 2020
Measuring treatment effect during a clinical trial is often the source of much debate, particularly during rare disease...
Read article
November 12, 2018
Can Statisticians Contribute to Enhance the Position of Patients in Clinical Trials?
In this blog, we talk with Robert Greene, Founder and President of the HungerNDThirst Foundation, about his upcoming...
Read article
October 5, 2018
Interview with Stephen Senn: 70 Years and Still Here: The Randomized Clinical Trial and its Critics
We are delighted that Stephen Senn will be joining us at the EUGM on November 14th and 15th in Darmstadt, Germany. In...
Read article
September 27, 2018
Decision Making in Development Programs with Targeted Therapies: with Heiko Götte
In this blog, we talk with Heiko Götte, Senior Expert Biostatistician at Merck about his upcoming presentation at...
Read article
August 15, 2018
2018 East User Group Meeting Addresses Multiplicity Themes, with keynotes including Stephen Senn and Meinhard Keiser.
Cytel’s 7th East User Group Meeting (EUGM) will take place on November 14 & 15, 2018 at Merck in Darmstadt, Germany,...
Read article
July 3, 2018
Unveiling New East 6.5 Modules: Join Our Webinar
It’s shaping up to be a busy year for Cytel’s software development team with a number of upgrades and planned launches...
Read article
October 18, 2017
Webinar Replay: Phase 2 Trial Designs using Program-level Simulations
Cytel's new Trial Innovations Webinar Series provides a platform for the most promising new statistical approaches...
Read article
August 10, 2017
4 Questions to Explore in Model-Informed Drug Development (Infographic)
Model-informed drug development has been defined by Richard Lalonde ( Lalonde, 2007) (1) as “Development and...
Read article
June 12, 2017
Predictions of Pharmacodynamic Responses in Ulcerative Colitis Patient
The Population Approach Group in Europe (PAGE) represents a community with a shared interest in data analysis using the...
Read article
October 11, 2016
Simulations to optimize clinical trial programs
Its important to take a strategic approach to clinical development in order to minimize the potential for Phase 3...
Read article
July 7, 2016
Wild Horses: How StatXact is helping conservation project in Mongolia
Why do we do what we do? At Cytel we have always been driven to deliver benefits in the service of human health, and...
Read article
September 4, 2015
Using Simulation for Accelerated Early Phase Drug Development
Our Client's Challenge: Can knowledge of the relationship between biomarkers and clinical endpoints help us to optimize...
Read article